Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Alexandros Spyridonidis (1968-)

Internist

Name

Alexandros Spyridonidis

Time

1968- (Date of birth and death)

Place

Thessaloniki (Geburtsort)
Deutschland
Griechenland

Gender

männlich

Academic degree

MD

Profession

Internist (characteristic profession)

Further information

Habil. Abt. Hämatologie/Onkologie; griech. Nationalität; Facharzt für Innere Medizin

Record type

Person

GND-Identifier

115781668

Record ID

115781668

Involved in

show all

Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients

Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide

Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party

Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT

Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Knochenmark : ein multifunktionelles, ex vivo modifizierbares, transplantierbares Organ

Verhalten von Mammakarzinomzellen während Ex-vivo-Expansion von CD34+ Blutvorläuferzellen
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal